Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Memory Mvula"'
Autor:
Memory Mvula, Fatima Mtonga, Jonathan Mandolo, Chisomo Jowati, Alice Kalirani, Precious Chigamba, Edwin Lisimba, Ndaona Mitole, Marah G. Chibwana, Kondwani C. Jambo
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hybrid immunity provides better protection against COVID-19 than vaccination or prior natural infection alone. It induces high magnitude and broadly cross-reactive neutralising anti-Spike IgG antibodies. However, it is not clear h
Externí odkaz:
https://doaj.org/article/05866432303f451aa80e29a42395b319
Autor:
Tiza L. Ng’uni, Vernon Musale, Thandeka Nkosi, Jonathan Mandolo, Memory Mvula, Clive Michelo, Farina Karim, Mohomed Yunus S. Moosa, Khadija Khan, Kondwani Charles Jambo, Willem Hanekom, Alex Sigal, William Kilembe, Zaza M. Ndhlovu
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundUnderstanding how HIV affects SARS-CoV-2 immunity is crucial for managing COVID-19 in sub-Saharan populations due to frequent coinfections. Our previous research showed that unsuppressed HIV is associated with weaker immune responses to SAR
Externí odkaz:
https://doaj.org/article/bf768e1f550c47c380042cc762cd9c8b
Autor:
Upendo L. Mseka, Jonathan Mandolo, Kenneth Nyoni, Oscar Divala, Dzinkambani Kambalame, Daniel Mapemba, Moses Kamzati, Innocent Chibwe, Marc Y.R. Henrion, Kingsley Manda, Deus Thindwa, Memory Mvula, Bright Odala, Raphael Kamng'ona, Nelson Dzinza, Khuzwayo C. Jere, Nicholas Feasey, Antonia Ho, Abena S. Amoah, Melita Gordon, Todd D. Swarthout, Amelia Crampin, Robert S. Heyderman, Matthew Kagoli, Evelyn Chitsa-Banda, Collins Mitambo, John Phuka, Benson Chilima, Watipaso Kasambara, Kondwani C. Jambo, Annie Chauma-Mwale
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101800- (2023)
Summary: Background: The B.1.1.529 (Omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the fourth COVID-19 pandemic wave across the southern African region, including Malawi. The seroprevalence of SARS-Co
Externí odkaz:
https://doaj.org/article/d886e6a896034979824c21646a6c6ea9
Autor:
Upendo L. Mseka, Jonathan Mandolo, Kenneth Nyoni, Oscar Divala, Dzinkambani Kambalame, Daniel Mapemba, Moses Kamzati, Innocent Chibwe, Marc Y.R. Henrion, Kingsley Manda, Deus Thindwa, Memory Mvula, Bright Odala, Raphael Kamng'ona, Nelson Dzinza, Khuzwayo C. Jere, Nicholas Feasey, Antonia Ho, Abena S. Amoah, Melita Gordon, Todd D. Swarthout, Amelia Crampin, Robert S. Heyderman, Matthew Kagoli, Evelyn Chitsa-Banda, Collins Mitambo, John Phuka, Benson Chilima, Watipaso Kasambara, Kondwani C. Jambo, Annie Chauma-Mwale
BackgroundThe B.1.1.529 (Omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the fourth COVID-19 pandemic wave across the southern African region, including Malawi. The seroprevalence of SARS-CoV-2 antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57df0647b7084f3b4e6001a30365fd0
https://doi.org/10.1101/2022.08.22.22279060
https://doi.org/10.1101/2022.08.22.22279060
